211: TWIN PETES INVESTING Podcast no.156: Would you like a 100% investing return? Spirax, Croda, Renishaw, Spectris, BP, Shell, Rotork, DGI9, Warehouse REIT, Thermo Fisher Scientific, The Investor Summit, Menphys Charity fundraise, FX, Tariffs, $KEY $AME $TDY

The topics, stocks and shares mentioned/discussed include: Spirax Group, Victrex, Rotork, Croda, Renishaw, Spectris, Warehouse REIT, Dividends, Wood Group, BP & Shell Thermo Fisher Scientific, The Investor Summit, Tariffs, FX Headwinds, Takeovers, Return on capital employed / ROCE Dividends / While you wait Investor Summit, Get your Early bird tickets now tickets 2025 Conference Tickets | Investor Summit Psychology Dividends Return on capital employed / ROCE Keysight Technologies / KEYS Agilent Technologies / A AMETEK Inc. / AME Fortive Corporation / FTV Teledyne Technologies /  TDY National Instruments /  NATI Investing / Trading & more The Investor Summit tickets 2025 Conference Tickets | Investor Summit ShareScope special discount offer code ShareScope : TwinPetes Harriman House books Harriman House – Independently minded publishing support the TwinPetesInvesting Challenge Investors’ Chronicle sponsor Special Trial Offers (investorschronicle.co.uk) the TwinPetesInvesting Challenge Henry Viola-Heir’s blog Home – The Ethical Entrepreneur Powder Monkey Brewing Co All Products – Powder Monkey Brewing Co 10% discount code : TWINPETES The 2025 TwinPetesInvesting MENPHYS Charity Appeal please make a donation on the TwinPetes Investing Charity Challenge 2025 Just Giving page here where  Peter Higgins & the TwinPetesInvesting podcast are fundraising for the children with disabilities charity, Menphys. The Twin Petes Investing podcasts will be linked to and written about on the Conkers3 website , on the Sharescope website and also on available via your favourite podcast and social media platforms. Thank you for reading this article and listening to this podcast, we hope you enjoyed it. Please share this article with others that you know will find it of interest.

There are no comments yet.

Please log in to write the first comment.